| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2002 | CA2418071A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis |
| 02/07/2002 | CA2417848A1 Compositions and methods for the treatment of anorectal disorders |
| 02/07/2002 | CA2417840A1 Bimodal emulsions of taxanes and butyrate polyalcohol esters |
| 02/07/2002 | CA2417788A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | CA2417671A1 Trp8, trp9 and trp10, novel markers for cancer |
| 02/07/2002 | CA2417650A1 Indazole derivatives as jnk inhibitors and compositions and methods related thereto |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417636A1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 02/07/2002 | CA2417627A1 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | CA2417566A1 Purifying crude pufa oils |
| 02/07/2002 | CA2417550A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | CA2417533A1 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | CA2417495A1 Methods for treating cell proliferative disorders and viral infections |
| 02/07/2002 | CA2417489A1 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | CA2417473A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase |
| 02/07/2002 | CA2417444A1 Nonsteroidal inflammation inhibitors |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417336A1 Method for reducing exacerbations associated with copd |
| 02/07/2002 | CA2417326A1 Method of increasing sensitivity of mammography |
| 02/07/2002 | CA2417304A1 Anticonvulsant derivatives useful for the treatment of depression |
| 02/07/2002 | CA2417277A1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta. |
| 02/07/2002 | CA2417262A1 Cdc25 phosphatase inhibitors |
| 02/07/2002 | CA2417260A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | CA2417259A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | CA2417254A1 N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | CA2417204A1 Imidazolyl derivatives |
| 02/07/2002 | CA2417121A1 Imidazo-pyrazine derivatives as ligands for gaba receptors |
| 02/07/2002 | CA2417064A1 Cyclic polyamine compounds for cancer therapy |
| 02/07/2002 | CA2417059A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | CA2416978A1 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | CA2416824A1 Use of an arylaldehyde 5-oxo-1, 2, 4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | CA2416694A1 Paroxetine tablets and capsules |
| 02/07/2002 | CA2416523A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | CA2416307A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | CA2416137A1 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | CA2416122A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | CA2415851A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | CA2415826A1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 02/07/2002 | CA2415789A1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | CA2415473A1 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | CA2415189A1 Immunomodulatory compounds |
| 02/07/2002 | CA2415078A1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | CA2414623A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | CA2388550A1 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | CA2385908A1 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
| 02/07/2002 | CA2319694A1 Compound |
| 02/06/2002 | EP1178111A1 Vaccination against host cell-associated herpesviruses |
| 02/06/2002 | EP1178104A1 Use of essential oils for combatting GI tract infection by helicobacter-like organisms |
| 02/06/2002 | EP1178103A1 Purifying crude pufa oils |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1178048A1 Azabicycloalkane derivatives for use as serotonin reuptake inhibitors and 5HT2a antagonists |
| 02/06/2002 | EP1178047A1 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 02/06/2002 | EP1178046A1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 02/06/2002 | EP1178044A1 Tocopherylalkoxylates, their preparation and their use in cosmetic and pharmaceutical forms |
| 02/06/2002 | EP1178041A1 Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives |
| 02/06/2002 | EP1178034A1 Alkyl amino acid derivatives useful as pharmaceutical agents |
| 02/06/2002 | EP1177798A2 A pharmaceutical composition for the treatment of attention deficit hyperactivity disorder(ADHD) comprising a nicotine receptor partial agonist and anti-ADHD agent |
| 02/06/2002 | EP1177797A1 Novel use |
| 02/06/2002 | EP1177796A1 Preventives/remedies for liver diseases |
| 02/06/2002 | EP1177795A2 Use of ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 02/06/2002 | EP1177793A1 Inhalable medicinal aerosol composition for pain treatment or prevention |
| 02/06/2002 | EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| 02/06/2002 | EP1177791A2 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 02/06/2002 | EP1177790A1 Therapy with cannabinoids in the treatment of cerebral tumor |
| 02/06/2002 | EP1177789A2 Use of phytanic acid for the treatment of diabetes |
| 02/06/2002 | EP1177788A2 Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture |
| 02/06/2002 | EP1177787A2 Use of an estrogen agonist/antagonist for treating cataracts |
| 02/06/2002 | EP1177785A2 Growth promoting pharmaceutical implant |
| 02/06/2002 | EP1177729A2 Pharmaceutical and food compositions containing "wood alcohols" or "wood sterols" useful for lowering serum cholesterol |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177217A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 02/06/2002 | EP1177206A1 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anaesthetic activity |
| 02/06/2002 | EP1177205A1 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS |
| 02/06/2002 | EP1177204A2 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 02/06/2002 | EP1177200A1 Ligands for metabotropic glutamate receptors |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177196A1 Heteroaryl diazabicycloalkanes, their preparation and use |
| 02/06/2002 | EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/06/2002 | EP1177192A2 Antifungal ethers |
| 02/06/2002 | EP1177191A1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 02/06/2002 | EP1177190A2 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177186A1 Ureas and their use as cell adhesion modulators |
| 02/06/2002 | EP1177185A1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
| 02/06/2002 | EP1177181A1 Substituted bicyclic compounds |
| 02/06/2002 | EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 02/06/2002 | EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1177171A1 Substituted indole sulfonamides as antiviral agents |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP1177167A2 High purity (1r, 2s, 4r)-(-)-2-[(2'-(n,n-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them. |
| 02/06/2002 | EP1177166A2 Process for preparing (1r,2s,4r) -(-)-2- (2'- n,n-dimethylamino -ethoxy)] -2- phenyl] -1,7,7-tri- methyl] -bicyclo 2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof |
| 02/06/2002 | EP1177016A2 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy |